Menu 
Global Site
Australia
Canada
China
France
Germany 
India
Netherlands
New Zealand
Romania 
Russia
South Africa
Spain
Ukraine
United Kingdom 
United States
Brazil
Our Story
Brand
Heritage
Our Founder
Milestones
An Unfinished Agenda
Leadership
Board Of Directors
Management Council 
Featured Stories
Our Products
Business Porfolio
Generics
Over-the-counter
APIs (Active Pharmaceutical Ingredients)
Biologics
Differentiated Formulations
Custom Pharma Services (CPS)
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Generics
APIs (Active Pharmaceutical Ingredients)
Biologics
Proprietary Products
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Our Approach
Education
Livelihoods 
Healthcare
Change Makers
Planet
Commitment to the Planet
Initiatives
Carbon Footprint
Affiliates
Dr Reddy’s Foundations 
Partners
Sustainability 
Investors
Reports and Filings 
Annual Reports
Quarterly Reports
Filings
34
th
 Annual General Meeting 
Voting Results
Moand AoA
Presentations 
Presentations
Earnings Call
Shares
Share Price
Stock Updates
Equity & Dividend History
Unpaid & Unclaimed Dividend
Analyst Coverage
Shareholding Pattern
Share Transfer Information
Buyback
Details of Shares for transfer to August 17
Notice pursuant to Rules, Aug 17
Details of Shares for transfer to May 2018
Notice pursuant to Rules, May 2018
Governance
Internal Control Systems
Committees of the Board
Code of Business Conduct and Ethics (COBE)
Ombudsperson Policy
Supplier Code of Conduct 
Compliance with NYSE
Information to Stakeholders
 Corporate Governance Reports
Policies and Documents
Data Privacy Notice
Investor Services
Statutory Communication
Shareholder’s Contacts 
Shareholder Information
Investor Meeting Details 
Other Stock Exchange Intimations
Media
Press Releases
Media Kit
in the news
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Canada
in Canada 
Our Products
Medical Information
Patient Care Program
Customer Service
Contact Us
Australia
in Australia
Our Products
Our Programmes
Contact Us
Germany 
in Germany 
Our Products
Us
India
Portfolio
Top Brands
Biosimilars 
Differentiated Products
List
Therapy Areas
Programs
For Doctors
For Patients
DRFHE
People
Careers
Medical Information
Contact Us
New Zealand
in New Zealand
Contact Us
China
Contact Us
Our Products
in China
Netherlands
Reddy’s Research and Development 
Join Us
Contact Us
Contact Us
Global Locations 
Key Contacts
Medical Information
Bringing expensive medicines within reach
Know More
Know More
Leveraging deep science for breaking
 new ground in cancer treatment
Know More
Accelerating access to high quality 
and affordable biosimilars
Know More
Our 
 Story
Our 
 Products
Our 
 People
Our 
 Science
Our 
 World
Earnings Call Notification - Q3 19
 | 
Earnings Call Transcript – Q2 FY19
 | 
Earnings Call Audio - Q2 19 
 | 
Q2 FY19: Financial Performance Press Release
Our Story
Our Brand
Our Heritage
Leadership
Featured Stories
Our Products
Business Focus
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Planet
Affiliates
Sustainability
Investors
Media
Partners
Contact Us
© 2018 Reddy’s All rights reserved.
Please read the legal notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Reddys its subsidiaries or affiliates.
Declaration | 
California Compliance | 
Privacy policy | 
Terms Of Use 
| Accessibility
| Cookie Policy
Cookie

                This website uses cookies to help us give you the best experience when you visit.
                By using this website you consent to our use of cookies. For more information please review our cookie policy.
                
Cookie Policy.
Accept

                You are about to leave Dr.Reddy’s and affiliates website. assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Reddy's.
            
If you wish to continue to this external website, click Proceed.
Proceed
BackMenu 
Global Site
Australia
Canada
China
France
Germany 
India
Netherlands
New Zealand
Romania 
Russia
South Africa
Spain
Ukraine
United Kingdom 
United States
Brazil
Our Story
Brand
Heritage
Our Founder
Milestones
An Unfinished Agenda
Leadership
Board Of Directors
Management Council 
Featured Stories
Our Products
Business Porfolio
Generics
Over-the-counter
APIs (Active Pharmaceutical Ingredients)
Biologics
Differentiated Formulations
Custom Pharma Services (CPS)
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Generics
APIs (Active Pharmaceutical Ingredients)
Biologics
Proprietary Products
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Our Approach
Education
Livelihoods 
Healthcare
Change Makers
Planet
Commitment to the Planet
Initiatives
Carbon Footprint
Affiliates
Dr Reddy’s Foundations 
Partners
Sustainability 
Investors
Reports and Filings 
Annual Reports
Quarterly Reports
Filings
34
th
 Annual General Meeting 
Voting Results
Moand AoA
Presentations 
Presentations
Earnings Call
Shares
Share Price
Stock Updates
Equity & Dividend History
Unpaid & Unclaimed Dividend
Analyst Coverage
Shareholding Pattern
Share Transfer Information
Buyback
Details of Shares for transfer to August 17
Notice pursuant to Rules, Aug 17
Details of Shares for transfer to May 2018
Notice pursuant to Rules, May 2018
Governance
Internal Control Systems
Committees of the Board
Code of Business Conduct and Ethics (COBE)
Ombudsperson Policy
Supplier Code of Conduct 
Compliance with NYSE
Information to Stakeholders
 Corporate Governance Reports
Policies and Documents
Data Privacy Notice
Investor Services
Statutory Communication
Shareholder’s Contacts 
Shareholder Information
Investor Meeting Details 
Other Stock Exchange Intimations
Media
Press Releases
Media Kit
in the news
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Canada
in Canada 
Our Products
Medical Information
Patient Care Program
Customer Service
Contact Us
Australia
in Australia
Our Products
Our Programmes
Contact Us
Germany 
in Germany 
Our Products
Us
India
Portfolio
Top Brands
Biosimilars 
Differentiated Products
List
Therapy Areas
Programs
For Doctors
For Patients
DRFHE
People
Careers
Medical Information
Contact Us
New Zealand
in New Zealand
Contact Us
China
Contact Us
Our Products
in China
Netherlands
Reddy’s Research and Development 
Join Us
Contact Us
Contact Us
Global Locations 
Key Contacts
Medical Information
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Title
Select
Mr.
 Ms.
 Prof.
First Name
Last Name
Email Address
Phone Number
Organization
Job Title
Address 1
Address 2
City
State
Zip Code
Post Code
Country
Relationship with Reddy’s
Select
Business Partner 
 Customer
 Shareholder or potential investor
Purpose for Contacting Reddy’s
Select
Business Development Opportunity
 Company Information
 Manufacturing
 Unit Dose Bar Code database request
 Application Request
 Formulation Manufacturing
 Press Request
 Printed materials request
 Product question or comment
 Website question or comment
Subject
Your message or question
Please confirm that you are not a robot
Earnings Call Notification - Q3 19
 | 
Earnings Call Transcript – Q2 FY19
 | 
Earnings Call Audio - Q2 19 
 | 
Q2 FY19: Financial Performance Press Release
Our Story
Our Brand
Our Heritage
Leadership
Featured Stories
Our Products
Business Focus
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Planet
Affiliates
Sustainability
Investors
Media
Partners
Contact Us
© 2018 Reddy’s All rights reserved.
Please read the legal notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Reddys its subsidiaries or affiliates.
Declaration | 
California Compliance | 
Privacy policy | 
Terms Of Use 
| Accessibility
| Cookie Policy
Cookie

                This website uses cookies to help us give you the best experience when you visit.
                By using this website you consent to our use of cookies. For more information please review our cookie policy.
                
Cookie Policy.
Accept

                You are about to leave Dr.Reddy’s and affiliates website. assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Reddy's.
            
If you wish to continue to this external website, click Proceed.
Proceed
BackMenu 
Global Site
Australia
Canada
China
France
Germany 
India
Netherlands
New Zealand
Romania 
Russia
South Africa
Spain
Ukraine
United Kingdom 
United States
Brazil
Our Story
Brand
Heritage
Our Founder
Milestones
An Unfinished Agenda
Leadership
Board Of Directors
Management Council 
Featured Stories
Our Products
Business Porfolio
Generics
Over-the-counter
APIs (Active Pharmaceutical Ingredients)
Biologics
Differentiated Formulations
Custom Pharma Services (CPS)
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Generics
APIs (Active Pharmaceutical Ingredients)
Biologics
Proprietary Products
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Our Approach
Education
Livelihoods 
Healthcare
Change Makers
Planet
Commitment to the Planet
Initiatives
Carbon Footprint
Affiliates
Dr Reddy’s Foundations 
Partners
Sustainability 
Investors
Reports and Filings 
Annual Reports
Quarterly Reports
Filings
34
th
 Annual General Meeting 
Voting Results
Moand AoA
Presentations 
Presentations
Earnings Call
Shares
Share Price
Stock Updates
Equity & Dividend History
Unpaid & Unclaimed Dividend
Analyst Coverage
Shareholding Pattern
Share Transfer Information
Buyback
Details of Shares for transfer to August 17
Notice pursuant to Rules, Aug 17
Details of Shares for transfer to May 2018
Notice pursuant to Rules, May 2018
Governance
Internal Control Systems
Committees of the Board
Code of Business Conduct and Ethics (COBE)
Ombudsperson Policy
Supplier Code of Conduct 
Compliance with NYSE
Information to Stakeholders
 Corporate Governance Reports
Policies and Documents
Data Privacy Notice
Investor Services
Statutory Communication
Shareholder’s Contacts 
Shareholder Information
Investor Meeting Details 
Other Stock Exchange Intimations
Media
Press Releases
Media Kit
in the news
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Canada
in Canada 
Our Products
Medical Information
Patient Care Program
Customer Service
Contact Us
Australia
in Australia
Our Products
Our Programmes
Contact Us
Germany 
in Germany 
Our Products
Us
India
Portfolio
Top Brands
Biosimilars 
Differentiated Products
List
Therapy Areas
Programs
For Doctors
For Patients
DRFHE
People
Careers
Medical Information
Contact Us
New Zealand
in New Zealand
Contact Us
China
Contact Us
Our Products
in China
Netherlands
Reddy’s Research and Development 
Join Us
Contact Us
Contact Us
Global Locations 
Key Contacts
Medical Information
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Prospective Partners 
Making a holistic impact on the health of patients worldwide requires us to work with partners across the healthcare value chain. From other pharmaceutical companies, doctors, healthcare professionals, hospitals, distribution networks and retailers, we work with all of them always keeping the end consumer – the patient at the center of all we do. We focus on our partners with a high-value strategic mindset and who place a premium on quality, compliance and relationships.
Business Partners
 Ensuring a continuous supply, remaining cost-competitive and guaranteeing highest quality are vital to provide affordable medicines to patients worldwide. To achieve this, we work with business partners in various ways across the value chain. We emphasize fair, transparent and ethical practices and seek partners who share the same commitment towards compliance with laws, regulations, published standards and environmental practices.
If you’re interested in partnering with Reddy’s, we’d love to hear of your products and services. Please do register with us 
 here
.
R&Partners
 Research and development is at the heart of all we do for patients. As an R&driven organization focused on innovation, we understand the value of shared knowledge and leveraged skills. This is why we actively seek out partnerships and collaboration within the industry that can help us successfully make high quality and affordable medicines. Our R&efforts have been leveraging external partnerships for one or more parts of the value chain – development, manufacturing or both. Currently we work with nearly 50 partners spread across the world, with the three major clusters being USA, Western Europe and India. We partner with organizations, which complement our strengths in development and/or manufacturing.
If there’s something that we could help you with, please do post your query here 
link
.
Earnings Call Notification - Q3 19
 | 
Earnings Call Transcript – Q2 FY19
 | 
Earnings Call Audio - Q2 19 
 | 
Q2 FY19: Financial Performance Press Release
Our Story
Our Brand
Our Heritage
Leadership
Featured Stories
Our Products
Business Focus
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Planet
Affiliates
Sustainability
Investors
Media
Partners
Contact Us
© 2018 Reddy’s All rights reserved.
Please read the legal notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Reddys its subsidiaries or affiliates.
Declaration | 
California Compliance | 
Privacy policy | 
Terms Of Use 
| Accessibility
| Cookie Policy
Cookie

                This website uses cookies to help us give you the best experience when you visit.
                By using this website you consent to our use of cookies. For more information please review our cookie policy.
                
Cookie Policy.
Accept

                You are about to leave Dr.Reddy’s and affiliates website. assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Reddy's.
            
If you wish to continue to this external website, click Proceed.
Proceed
BackMenu 
Global Site
Australia
Canada
China
France
Germany 
India
Netherlands
New Zealand
Romania 
Russia
South Africa
Spain
Ukraine
United Kingdom 
United States
Brazil
Our Story
Brand
Heritage
Our Founder
Milestones
An Unfinished Agenda
Leadership
Board Of Directors
Management Council 
Featured Stories
Our Products
Business Porfolio
Generics
Over-the-counter
APIs (Active Pharmaceutical Ingredients)
Biologics
Differentiated Formulations
Custom Pharma Services (CPS)
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Generics
APIs (Active Pharmaceutical Ingredients)
Biologics
Proprietary Products
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Our Approach
Education
Livelihoods 
Healthcare
Change Makers
Planet
Commitment to the Planet
Initiatives
Carbon Footprint
Affiliates
Dr Reddy’s Foundations 
Partners
Sustainability 
Investors
Reports and Filings 
Annual Reports
Quarterly Reports
Filings
34
th
 Annual General Meeting 
Voting Results
Moand AoA
Presentations 
Presentations
Earnings Call
Shares
Share Price
Stock Updates
Equity & Dividend History
Unpaid & Unclaimed Dividend
Analyst Coverage
Shareholding Pattern
Share Transfer Information
Buyback
Details of Shares for transfer to August 17
Notice pursuant to Rules, Aug 17
Details of Shares for transfer to May 2018
Notice pursuant to Rules, May 2018
Governance
Internal Control Systems
Committees of the Board
Code of Business Conduct and Ethics (COBE)
Ombudsperson Policy
Supplier Code of Conduct 
Compliance with NYSE
Information to Stakeholders
 Corporate Governance Reports
Policies and Documents
Data Privacy Notice
Investor Services
Statutory Communication
Shareholder’s Contacts 
Shareholder Information
Investor Meeting Details 
Other Stock Exchange Intimations
Media
Press Releases
Media Kit
in the news
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Canada
in Canada 
Our Products
Medical Information
Patient Care Program
Customer Service
Contact Us
Australia
in Australia
Our Products
Our Programmes
Contact Us
Germany 
in Germany 
Our Products
Us
India
Portfolio
Top Brands
Biosimilars 
Differentiated Products
List
Therapy Areas
Programs
For Doctors
For Patients
DRFHE
People
Careers
Medical Information
Contact Us
New Zealand
in New Zealand
Contact Us
China
Contact Us
Our Products
in China
Netherlands
Reddy’s Research and Development 
Join Us
Contact Us
Contact Us
Global Locations 
Key Contacts
Medical Information
Our  Citizenship
Patients
Healthcare Professionals
Community
Planet
Affiliates
Sustainability 
Affiliates
Dr Reddy’s Foundations 
Partners
Partners
Naandi Foundation
Naandi was founded on November 1, 1998, as a Public Charitable Trust. Born out of the idea of creating a professionally run organization managed by eminent business leaders as trustees, Naandi demonstrates the strength of multi-sector partnerships for delivering results in the socio-development sector of India. Naandi delivers services, such as elementary education, with positive discrimination of girls, safe drinking water and sanitation, large scale cooperative irrigated farming in dry-land areas, end-to-end sustainable agriculture in tribal areas, skilling and employment for youth, safe motherhood and early childhood development, including tackling of malnutrition among children.
Read more about Naandi Foundation 
here
Foundation
Dedicated to improving maternal health and combating infant and child mortality, the Foundation provides quality healthcare to the poorest, the most neglected and the most deserving in our society. foundation has a balanced team of medical professionals with updated expertise in health and grass-root workers who understand the community health through close and consistent engagement. With an in-depth experience of working for well-being of newborns, tribals and schools, the foundation brings strengths of high clinical and preventive expertise combined withsensitivity to access issues, and the need for preventive approaches and cultural dimensions of health problems.
Read more about Foundation 
here
Center for Social Initiative and Management
The program develops social-change agents through training, networking,and interningopporunitties.  The program connects participants to alumni and academics who are active in the social enterprise development.  Many of alumni have become significant contributors to social progress. alumni are generating social benefits in diverse fields like rural development, education, livelihoods, health, water and sanitation, disability, child protection, old-age homes, and orphanages.
Read more about 
here
Teach for India 
The Teach for India (TFI) program holds that every child must attain an excellent education. In pursuit of this vision, nurtures young professionals and graduates who take up full-time teaching careers in low-income government and private schools. Their journey transforms them into leaders with a mission to end educational inequity. In line with this vision, the partnership between Reddy’s and enhances school efficiency and inspires fellows to become more adaptable, open-minded, and resourceful.  This partnership not only provides guidance in positioning the fellows as Teacher Trainers, School leaders, Curriculum Designers etc, but also inspires children in different classrooms by creating a space for them to interact with Dr Reddy’s employees’.
Read more about 
here
Earnings Call Notification - Q3 19
 | 
Earnings Call Transcript – Q2 FY19
 | 
Earnings Call Audio - Q2 19 
 | 
Q2 FY19: Financial Performance Press Release
Our Story
Our Brand
Our Heritage
Leadership
Featured Stories
Our Products
Business Focus
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Planet
Affiliates
Sustainability
Investors
Media
Partners
Contact Us
© 2018 Reddy’s All rights reserved.
Please read the legal notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Reddys its subsidiaries or affiliates.
Declaration | 
California Compliance | 
Privacy policy | 
Terms Of Use 
| Accessibility
| Cookie Policy
Cookie

                This website uses cookies to help us give you the best experience when you visit.
                By using this website you consent to our use of cookies. For more information please review our cookie policy.
                
Cookie Policy.
Accept

                You are about to leave Dr.Reddy’s and affiliates website. assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Reddy's.
            
If you wish to continue to this external website, click Proceed.
Proceed
BackMenu 
Global Site
Australia
Canada
China
France
Germany 
India
Netherlands
New Zealand
Romania 
Russia
South Africa
Spain
Ukraine
United Kingdom 
United States
Brazil
Our Story
Brand
Heritage
Our Founder
Milestones
An Unfinished Agenda
Leadership
Board Of Directors
Management Council 
Featured Stories
Our Products
Business Porfolio
Generics
Over-the-counter
APIs (Active Pharmaceutical Ingredients)
Biologics
Differentiated Formulations
Custom Pharma Services (CPS)
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Generics
APIs (Active Pharmaceutical Ingredients)
Biologics
Proprietary Products
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Our Approach
Education
Livelihoods 
Healthcare
Change Makers
Planet
Commitment to the Planet
Initiatives
Carbon Footprint
Affiliates
Dr Reddy’s Foundations 
Partners
Sustainability 
Investors
Reports and Filings 
Annual Reports
Quarterly Reports
Filings
34
th
 Annual General Meeting 
Voting Results
Moand AoA
Presentations 
Presentations
Earnings Call
Shares
Share Price
Stock Updates
Equity & Dividend History
Unpaid & Unclaimed Dividend
Analyst Coverage
Shareholding Pattern
Share Transfer Information
Buyback
Details of Shares for transfer to August 17
Notice pursuant to Rules, Aug 17
Details of Shares for transfer to May 2018
Notice pursuant to Rules, May 2018
Governance
Internal Control Systems
Committees of the Board
Code of Business Conduct and Ethics (COBE)
Ombudsperson Policy
Supplier Code of Conduct 
Compliance with NYSE
Information to Stakeholders
 Corporate Governance Reports
Policies and Documents
Data Privacy Notice
Investor Services
Statutory Communication
Shareholder’s Contacts 
Shareholder Information
Investor Meeting Details 
Other Stock Exchange Intimations
Media
Press Releases
Media Kit
in the news
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Canada
in Canada 
Our Products
Medical Information
Patient Care Program
Customer Service
Contact Us
Australia
in Australia
Our Products
Our Programmes
Contact Us
Germany 
in Germany 
Our Products
Us
India
Portfolio
Top Brands
Biosimilars 
Differentiated Products
List
Therapy Areas
Programs
For Doctors
For Patients
DRFHE
People
Careers
Medical Information
Contact Us
New Zealand
in New Zealand
Contact Us
China
Contact Us
Our Products
in China
Netherlands
Reddy’s Research and Development 
Join Us
Contact Us
Contact Us
Global Locations 
Key Contacts
Medical Information
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Login for Current Partners
Existing Partner? Login 
here
.
This portal provides instant access to RFx, Purchase Orders, ASN's, GRN's, Invoice statuses, and more.
Earnings Call Notification - Q3 19
 | 
Earnings Call Transcript – Q2 FY19
 | 
Earnings Call Audio - Q2 19 
 | 
Q2 FY19: Financial Performance Press Release
Our Story
Our Brand
Our Heritage
Leadership
Featured Stories
Our Products
Business Focus
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Planet
Affiliates
Sustainability
Investors
Media
Partners
Contact Us
© 2018 Reddy’s All rights reserved.
Please read the legal notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Reddys its subsidiaries or affiliates.
Declaration | 
California Compliance | 
Privacy policy | 
Terms Of Use 
| Accessibility
| Cookie Policy
Cookie

                This website uses cookies to help us give you the best experience when you visit.
                By using this website you consent to our use of cookies. For more information please review our cookie policy.
                
Cookie Policy.
Accept

                You are about to leave Dr.Reddy’s and affiliates website. assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Reddy's.
            
If you wish to continue to this external website, click Proceed.
Proceed
BackMenu 
Global Site
Australia
Canada
China
France
Germany 
India
Netherlands
New Zealand
Romania 
Russia
South Africa
Spain
Ukraine
United Kingdom 
United States
Brazil
Our Story
Brand
Heritage
Our Founder
Milestones
An Unfinished Agenda
Leadership
Board Of Directors
Management Council 
Featured Stories
Our Products
Business Porfolio
Generics
Over-the-counter
APIs (Active Pharmaceutical Ingredients)
Biologics
Differentiated Formulations
Custom Pharma Services (CPS)
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Generics
APIs (Active Pharmaceutical Ingredients)
Biologics
Proprietary Products
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Our Approach
Education
Livelihoods 
Healthcare
Change Makers
Planet
Commitment to the Planet
Initiatives
Carbon Footprint
Affiliates
Dr Reddy’s Foundations 
Partners
Sustainability 
Investors
Reports and Filings 
Annual Reports
Quarterly Reports
Filings
34
th
 Annual General Meeting 
Voting Results
Moand AoA
Presentations 
Presentations
Earnings Call
Shares
Share Price
Stock Updates
Equity & Dividend History
Unpaid & Unclaimed Dividend
Analyst Coverage
Shareholding Pattern
Share Transfer Information
Buyback
Details of Shares for transfer to August 17
Notice pursuant to Rules, Aug 17
Details of Shares for transfer to May 2018
Notice pursuant to Rules, May 2018
Governance
Internal Control Systems
Committees of the Board
Code of Business Conduct and Ethics (COBE)
Ombudsperson Policy
Supplier Code of Conduct 
Compliance with NYSE
Information to Stakeholders
 Corporate Governance Reports
Policies and Documents
Data Privacy Notice
Investor Services
Statutory Communication
Shareholder’s Contacts 
Shareholder Information
Investor Meeting Details 
Other Stock Exchange Intimations
Media
Press Releases
Media Kit
in the news
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Canada
in Canada 
Our Products
Medical Information
Patient Care Program
Customer Service
Contact Us
Australia
in Australia
Our Products
Our Programmes
Contact Us
Germany 
in Germany 
Our Products
Us
India
Portfolio
Top Brands
Biosimilars 
Differentiated Products
List
Therapy Areas
Programs
For Doctors
For Patients
DRFHE
People
Careers
Medical Information
Contact Us
New Zealand
in New Zealand
Contact Us
China
Contact Us
Our Products
in China
Netherlands
Reddy’s Research and Development 
Join Us
Contact Us
Contact Us
Global Locations 
Key Contacts
Medical Information
Our Story
Brand
Heritage
Leadership
Featured Stories
Leadership
Board Of Directors
Management Council 
Management Council 
Inspiring Leadership
Our Management Council ensures that everything we do leads to perfect alignment - between our purpose of addressing patients’ needs, and our business goals. Consisting of senior management members from various functions, the Council decides on our company’s long term strategy, growth initiatives and overall organizational health. Our Management Council plays an important role in ensuring safe and productive operations, as well as in controlling risks in the business.
Whole Time Directors
Satish Reddy
Prasad
Management Team
Erez Israeli
Saumen Chakraborty 
Archana Bhaskar
Ramana
Sanjay Sharma 
Sauri Gudlavalleti
Ganadhish Kamat 
Anil Namboodiripad
Yugandhar Puvvala
Raymond De Vré
Deepak Sapra
Earnings Call Notification - Q3 19
 | 
Earnings Call Transcript – Q2 FY19
 | 
Earnings Call Audio - Q2 19 
 | 
Q2 FY19: Financial Performance Press Release
Our Story
Our Brand
Our Heritage
Leadership
Featured Stories
Our Products
Business Focus
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Planet
Affiliates
Sustainability
Investors
Media
Partners
Contact Us
© 2018 Reddy’s All rights reserved.
Please read the legal notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Reddys its subsidiaries or affiliates.
Declaration | 
California Compliance | 
Privacy policy | 
Terms Of Use 
| Accessibility
| Cookie Policy
Cookie

                This website uses cookies to help us give you the best experience when you visit.
                By using this website you consent to our use of cookies. For more information please review our cookie policy.
                
Cookie Policy.
Accept

                You are about to leave Dr.Reddy’s and affiliates website. assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Reddy's.
            
If you wish to continue to this external website, click Proceed.
Proceed
BackMenu 
Global Site
Australia
Canada
China
France
Germany 
India
Netherlands
New Zealand
Romania 
Russia
South Africa
Spain
Ukraine
United Kingdom 
United States
Brazil
Our Story
Brand
Heritage
Our Founder
Milestones
An Unfinished Agenda
Leadership
Board Of Directors
Management Council 
Featured Stories
Our Products
Business Porfolio
Generics
Over-the-counter
APIs (Active Pharmaceutical Ingredients)
Biologics
Differentiated Formulations
Custom Pharma Services (CPS)
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Generics
APIs (Active Pharmaceutical Ingredients)
Biologics
Proprietary Products
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Our Approach
Education
Livelihoods 
Healthcare
Change Makers
Planet
Commitment to the Planet
Initiatives
Carbon Footprint
Affiliates
Dr Reddy’s Foundations 
Partners
Sustainability 
Investors
Reports and Filings 
Annual Reports
Quarterly Reports
Filings
34
th
 Annual General Meeting 
Voting Results
Moand AoA
Presentations 
Presentations
Earnings Call
Shares
Share Price
Stock Updates
Equity & Dividend History
Unpaid & Unclaimed Dividend
Analyst Coverage
Shareholding Pattern
Share Transfer Information
Buyback
Details of Shares for transfer to August 17
Notice pursuant to Rules, Aug 17
Details of Shares for transfer to May 2018
Notice pursuant to Rules, May 2018
Governance
Internal Control Systems
Committees of the Board
Code of Business Conduct and Ethics (COBE)
Ombudsperson Policy
Supplier Code of Conduct 
Compliance with NYSE
Information to Stakeholders
 Corporate Governance Reports
Policies and Documents
Data Privacy Notice
Investor Services
Statutory Communication
Shareholder’s Contacts 
Shareholder Information
Investor Meeting Details 
Other Stock Exchange Intimations
Media
Press Releases
Media Kit
in the news
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Canada
in Canada 
Our Products
Medical Information
Patient Care Program
Customer Service
Contact Us
Australia
in Australia
Our Products
Our Programmes
Contact Us
Germany 
in Germany 
Our Products
Us
India
Portfolio
Top Brands
Biosimilars 
Differentiated Products
List
Therapy Areas
Programs
For Doctors
For Patients
DRFHE
People
Careers
Medical Information
Contact Us
New Zealand
in New Zealand
Contact Us
China
Contact Us
Our Products
in China
Netherlands
Reddy’s Research and Development 
Join Us
Contact Us
Contact Us
Global Locations 
Key Contacts
Medical Information
Investors
Reports and Filings 
Presentations 
Shares
Governance
Investor Services
Shares
Share Price
Stock Updates
Equity & Dividend History
Unpaid & Unclaimed Dividend
Analyst Coverage
Shareholding Pattern
Share Transfer Information
Buyback
Details of Shares for transfer to August 17
Notice pursuant to Rules, Aug 17
Details of Shares for transfer to May 2018
Notice pursuant to Rules, May 2018
Equity & Dividend History
HISTORY
/ YEAR
PARTICULARS
ISSUED
CANCELLED
CUMULATIVE
24-Feb-84
Issue to Promoters
200
200
22-Nov-84
Issue to Promoters
243,300
243,500
14-Jun-86
Issue to Promoters
6,500
250,000
09-Aug-86
Issue to Public
1,116,250
1,366,250
30-Sep-88
Forfeiture of 100 shares
100
1,366,150
09-Aug-89
Rights Issue
819,750
2,185,900
16-Dec-91
Bonus Issue (1:2)
1,092,950
3,278,850
17-Jan-93
Bonus Issue (1:1)
3,278,850
6,557,700
10-May-94
Bonus Issue (2:1)
13,115,400
19,673,100
10-May-94
Issue to Promoters
2,250,000
21,923,100
26-Jul-94
underlying Equity Shares
4,301,076
26,224,176
29-Sep-95
Shareholders on merger
263,062
26,487,238
30-Jan-01
Shareholders on merger
5,142,942
31,630,180
30-Jan-01
Cancellation of shares held in CDL
41,400
31,588,780
11-Apr-01
underlying Equity Shares
6,612,500
38,201,280
09-Jul-01
conversion into ADR
38,201,280
24-Sep-01
Shareholders on merger
56,694
38,257,974
25-Oct-01
Sub division of equity shares*
76,515,948
30-Jan-04
Allotment pursuant to exercise of Stock Options
3,001
76,518,949
2005-06
Allotment pursuant to exercise of Stock Options
175,621
76,694,570
2006-07
Allotment pursuant to exercise of Stock Options
63,232
76,757,802
30-Aug-06
Bonus Issue (1:1)
76,757,802
153,515,604
22-Nov-06
underlying Equity Shares
12,500,000
166,015,604
29-Nov-06
underlying Equity Shares (Green Shoe option)
1,800,000
167,815,604
2006-07
Allotment pursuant to exercise of Stock Options
96,576
167,912,180
2007-08
Allotment pursuant to exercise of Stock Options
260,566
168,172,746
2008-09
Allotment pursuant to exercise of Stock Options
296,031
168,468,777
2009-10
Allotment pursuant to exercise of Stock Options
376,608
168,845,385
2010-11
Allotment pursuant to exercise of Stock Options
407,347
169,252,732
2011-12
Allotment pursuant to exercise of Stock Options
307,614
169,560,346
2012-13
Allotment pursuant to exercise of Stock Options
276,129
169,836,475
2013-14
Allotment pursuant to exercise of Stock Options
272,393
170,108,868
2014-15
Allotment pursuant to exercise of Stock Options
272,306
170,381,174
2015-16
Allotment pursuant to exercise of Stock Options
226,479
170,607,653
During the quarter ended June 30, 2016, the Company bought back and extinguished 50,77,504 equity shares according to the provisions of (Buyback of Securities) Regulations,1998
5,077,504
165,530,149
2016-17
Allotment pursuant to exercise of Stock Options
211,564
165,741,713
2017-18
Allotment pursuant to exercise of Stock Options
169,194
165,910,907
14-Apr-18
Allotment pursuant to exercise of Stock Options
19,089
165,929,996
12-Jun-18
Allotment pursuant to exercise of Stock Options
43,232
165,973,228
06-Jul-18
Allotment pursuant to exercise of Stock Options
25,606
165,998,834
22-Aug-18
Allotment pursuant to exercise of Stock Options
31,046
166,029,880
25-Sep-18
Allotment pursuant to exercise of Stock Options
15,977
166,045,857
* Subdivision of 1 equity share of Rs 10/- face value into 2 equity shares of Rs 5/- face value each
HISTORY
Year ended
Interim % 
Final %
Total %
1996 - 97
-
30
30
1997 - 98
-
30
30
1998 - 99
-
30
30
1999 - 00
25
5
30
2000 - 01
-
40
40
2001 - 02
100
50
150
2002 - 03
-
100
100
2003 - 04
-
100
100
2004 - 05
-
100
100
2005 - 06
-
100
100
2006 - 07
-
75
75
2007 - 08
-
75
75
2008 - 09
-
125
125
2009-10
-
225
225
2010-11
-
225
225
2011-12
-
275
275
2012-13
-
300
300
2013-14
-
360
360
2014-15
-
400
400
2015-16
-
400
400
2016-17
-
400
400
2017-18
-
400
400
Earnings Call Notification - Q3 19
 | 
Earnings Call Transcript – Q2 FY19
 | 
Earnings Call Audio - Q2 19 
 | 
Q2 FY19: Financial Performance Press Release
Our Story
Our Brand
Our Heritage
Leadership
Featured Stories
Our Products
Business Focus
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Planet
Affiliates
Sustainability
Investors
Media
Partners
Contact Us
© 2018 Reddy’s All rights reserved.
Please read the legal notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Reddys its subsidiaries or affiliates.
Declaration | 
California Compliance | 
Privacy policy | 
Terms Of Use 
| Accessibility
| Cookie Policy
Cookie

                This website uses cookies to help us give you the best experience when you visit.
                By using this website you consent to our use of cookies. For more information please review our cookie policy.
                
Cookie Policy.
Accept

                You are about to leave Dr.Reddy’s and affiliates website. assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Reddy's.
            
If you wish to continue to this external website, click Proceed.
Proceed
BackMenu 
Global Site
Australia
Canada
China
France
Germany 
India
Netherlands
New Zealand
Romania 
Russia
South Africa
Spain
Ukraine
United Kingdom 
United States
Brazil
Our Story
Brand
Heritage
Our Founder
Milestones
An Unfinished Agenda
Leadership
Board Of Directors
Management Council 
Featured Stories
Our Products
Business Porfolio
Generics
Over-the-counter
APIs (Active Pharmaceutical Ingredients)
Biologics
Differentiated Formulations
Custom Pharma Services (CPS)
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Generics
APIs (Active Pharmaceutical Ingredients)
Biologics
Proprietary Products
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Our Approach
Education
Livelihoods 
Healthcare
Change Makers
Planet
Commitment to the Planet
Initiatives
Carbon Footprint
Affiliates
Dr Reddy’s Foundations 
Partners
Sustainability 
Investors
Reports and Filings 
Annual Reports
Quarterly Reports
Filings
34
th
 Annual General Meeting 
Voting Results
Moand AoA
Presentations 
Presentations
Earnings Call
Shares
Share Price
Stock Updates
Equity & Dividend History
Unpaid & Unclaimed Dividend
Analyst Coverage
Shareholding Pattern
Share Transfer Information
Buyback
Details of Shares for transfer to August 17
Notice pursuant to Rules, Aug 17
Details of Shares for transfer to May 2018
Notice pursuant to Rules, May 2018
Governance
Internal Control Systems
Committees of the Board
Code of Business Conduct and Ethics (COBE)
Ombudsperson Policy
Supplier Code of Conduct 
Compliance with NYSE
Information to Stakeholders
 Corporate Governance Reports
Policies and Documents
Data Privacy Notice
Investor Services
Statutory Communication
Shareholder’s Contacts 
Shareholder Information
Investor Meeting Details 
Other Stock Exchange Intimations
Media
Press Releases
Media Kit
in the news
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Canada
in Canada 
Our Products
Medical Information
Patient Care Program
Customer Service
Contact Us
Australia
in Australia
Our Products
Our Programmes
Contact Us
Germany 
in Germany 
Our Products
Us
India
Portfolio
Top Brands
Biosimilars 
Differentiated Products
List
Therapy Areas
Programs
For Doctors
For Patients
DRFHE
People
Careers
Medical Information
Contact Us
New Zealand
in New Zealand
Contact Us
China
Contact Us
Our Products
in China
Netherlands
Reddy’s Research and Development 
Join Us
Contact Us
Contact Us
Global Locations 
Key Contacts
Medical Information
Investors
Reports and Filings 
Presentations 
Shares
Governance
Investor Services
Governance
Internal Control Systems
Committees of the Board
Code of Business Conduct and Ethics (COBE)
Ombudsperson Policy
Supplier Code of Conduct 
Compliance with NYSE
Information to Stakeholders
 Corporate Governance Reports
Policies and Documents
Data Privacy Notice
 Corporate Governance Reports
Recent Yrs.
FY19
FY18
FY17
FY16
FY15
Prev Yrs.
June
Corporate Governance Report for quarter ended June 30, 2018
September
Corporate Governance Report for quarter ended September 30, 2018
December
Corporate Governance Report for quarter ended December 31, 2018 
Earnings Call Notification - Q3 19
 | 
Earnings Call Transcript – Q2 FY19
 | 
Earnings Call Audio - Q2 19 
 | 
Q2 FY19: Financial Performance Press Release
Our Story
Our Brand
Our Heritage
Leadership
Featured Stories
Our Products
Business Focus
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Capabilities
Our People
Humans of Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Planet
Affiliates
Sustainability
Investors
Media
Partners
Contact Us
© 2018 Reddy’s All rights reserved.
Please read the legal notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Reddys its subsidiaries or affiliates.
Declaration | 
California Compliance | 
Privacy policy | 
Terms Of Use 
| Accessibility
| Cookie Policy
Cookie

                This website uses cookies to help us give you the best experience when you visit.
                By using this website you consent to our use of cookies. For more information please review our cookie policy.
                
Cookie Policy.
Accept

                You are about to leave Dr.Reddy’s and affiliates website. assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Reddy's.
            
If you wish to continue to this external website, click Proceed.
Proceed
Back